Home
Projects
Specifications
HCT 3012 - COX-Inhibiting Nitric Oxide-Donator (CINOD) for Relief of Pain and Inflammation
Email Article
 
Print
Key Facts
Key Data:
Drug (brand / generic)
HCT 3012
Company/Licensee
NicOx SA
Therapy Class
CINOD
Product Description
COX-inhibiting nitric oxide donator
Current Indication
Treatment of acute and chronic nociceptive pain
Market Sector
Pain (analgesics/antiinflammtories)
Development Status
Phase III
Return to Project
Home
|
New On This Site
|
Products & Services
|
Company A-Z
|
Industry Projects
|
White Papers
|
Jobs & Careers
|
Press Releases
|
Events & Exhibitions
|
Newsletter
|
Organisations
|
About Us
|
Contact Us
|
Advertise With Us
|
Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area
For every phase of your drug development
Search